SCHEMBL19475147

SCHEMBL19475147

COc1cc(OC(N)=O)cc(N2CCOCC2)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.51
MAPT P10636 7/20 0.50
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 2/20 0.50
HTT P42858 1/20 0.50
RAB9A P51151 1/20 0.49
PRKDC P78527 1/20 0.49
FGFR2 P21802 1/20 0.48
FGFR3 P22607 1/20 0.48
TSHR P16473 1/20 0.48
ADRB1 P08588 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
PKM P14618 1/20 0.46
HIF1A Q16665 1/20 0.45
FAAH O00519 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
HCRTR1 O43613 1/20 0.44
ABCB1 P08183 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19475144 0.86 LMNA (0.54) AKR1C3MAPTKDM4EALDH1A1HTT
SCHEMBL5448570 0.84 ADRB1 (0.61) AKR1C3MAPTKDM4EALDH1A1HTT
SCHEMBL3914229 0.82 AKR1C3 (0.51) AKR1C3MAPTKDM4EALDH1A1HTT
SCHEMBL15546841 0.79 KMO (0.57) AKR1C3MAPTKDM4EALDH1A1MEN1
SCHEMBL11963589 0.78 MAPT (0.54) AKR1C3MAPTKDM4EALDH1A1HTT
SCHEMBL27922475 0.78 KDM4E (0.52) AKR1C3MAPTKDM4EALDH1A1HTT
SCHEMBL9231063 0.77 PRKDC (0.51) AKR1C3MAPTKDM4EALDH1A1HTT
SCHEMBL29833111 0.77 PRKDC (0.51) AKR1C3MAPTKDM4EALDH1A1HTT
SCHEMBL5123031 0.77 PRKDC (0.51) AKR1C3MAPTKDM4EALDH1A1HTT
SCHEMBL28304654 0.77 L3MBTL1 (0.62) AKR1C3MAPTKDM4EALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017184589-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS THE SCRIPPS RESEARCH INSTITUTE (US) 2017-10-26 WO disclosed